José Manuel
Aramendía Beitia
Consultor Médico
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (6)
2023
-
A pharmacometrics model to define docetaxel target in early breast cancer
British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
2021
-
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
British Journal of Cancer, Vol. 124, Núm. 6, pp. 1138-1149
2020
-
Complete cytoreductive surgery, the key factor for survival in advanced ovarian cancer. Experience of an intermediate volume hospital
European Journal of Gynaecological Oncology, Vol. 41, Núm. 6, pp. 906-912
2019
-
Dietary inflammatory index and incidence of breast cancer in the SUN project
Clinical Nutrition, Vol. 38, Núm. 5, pp. 2259-2268
2015
-
37th Annual San Antonio Breast Cancer Symposium. Summary of the most important translational and clinical contributions
Revista de Senologia y Patologia Mamaria